These tests look for early signs of problems, such as pre-eclampsia. Try not to miss them and if you do miss one, rearrange it. Even if you feel fine, it is best to be sure.
Routine tests in pregnancy
You will be offered tests and checks in pregnancy to keep an eye on your health and your baby's health.The same routine tests are offered to all pregnant women at antenatal appointments. You will also be given information to help you decide whether you want to have them. Find out more about routine tests in pregnancy here.
You will be offered at least two ultrasound scans during your pregnancy. If you have any pregnancy complications and your baby needs more checks you might have more scans. The first routine ultrasound scan will happen around week 11-14 to confirm the baby’s due date and the number of babies that you’re expecting. The second ultrasound scan will happen around week 20 to check that your baby is developing healthily. Find out more about ultrasound scans in pregnancy here.
Screening and diagnostic tests in pregnancy
A screening test checks if your baby has a high risk of having a particular condition, such as Down’s Syndrome. All women are offered a screening test. If the screening test shows up any complications then you will be offered diagnostic tests, which can tell you whether your baby has the condition. There are some different types of screening and diagnostic tests. To find out which tests your hospital offers you should ask your midwife how it works in your area.
Gestational diabetes is one of the conditions that midwives will be looking out for during your normal appointment schedule. If you have it, it will be spotted through tests.
It depends on which tests you want but most of the tests that check your own health can be started whenever you begin your antenatal care – even if it’s later in pregnancy.
An ultrasound scan is a way of looking at your baby in the womb. Scans can check the date your baby is due, tell whether you're having more than one baby and pick up on some possible problems.
1. National Institute for Health and Care Excellence (2008) ‘Antenatal Care. Appendix D: Antenatal appointments (schedule and content)’, NICE Clinical Guideline 62: https://www.nice.org.uk/guidance/cg62/chapter/appendix-d-antenatal-appointments-schedule-and-content [accessed 10 February 2015].
2. NHS Fetal Anomaly Screening Programme (2010) Standards and Guidance, Exeter, NHS Fetal Anomaly Screening Programme: http://www.fetalanomaly.screening.nhs.uk/fetalanomalyresource/images/stories/Downloads/2.6.1/nhs_fasp-all-standards-and-guidelines.pdf [accessed 10 February 2015].
3. National Institute for Health and Care Excellence (2008) ‘Antenatal Care. Statement 1.10: Fetal growth and well-being’, NICE Clinical Guideline 62: https://www.nice.org.uk/guidance/cg62/chapter/1-guidance#fetal-growth-and-wellbeing [accessed 10 February 2015].
4. National Institute for Health and Care Excellence (2011) ‘Multiple pregnancy: The management of twin and triplet pregnancies in the antenatal period’, NICE Clinical Guideline 129: http://www.nice.org.uk/guidance/cg129 [accessed 10 February 2015] (next review date: June 2016).
13. ‘Chorionic villus sampling’, NHS Choices: http://www.nhs.uk/conditions/chorionic-villus-sampling/Pages/Introduction.aspx [accessed 10 February 2015] (last reviewed: 14 October 2013; next review due: 14 October 2015); RCOG (2010) Amniocentesis and Chorionic Villus Sampling: Green-top Guideline No. 8, London, Royal College of Obstetricians and Gynaecologists (reviewed: 2014).
14. Amniocentesis’, NHS Choices: http://www.nhs.uk/conditions/Amniocentesis/Pages/Introduction.aspx [accessed 10 February 2015] (last reviewed: 27 May 2014; next review due: 27 May 2016); RCOG (2010) Amniocentesis and Chorionic Villus Sampling: Green-top Guideline No. 8, London, Royal College of Obstetricians and Gynaecologists (reviewed: 2014).
15. New Down’s syndrome blood test “more reliable”’, NHS Choices news report, 7 June 2013: http://www.nhs.uk/news/2013/06June/Pages/New-Downs-syndrome-blood-test-more-reliable.aspx[accessed 10 February 2015]; Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH (2013)
16. ‘Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies’, Ultrasound in Obstetrics & Gynecology 42 (1): 34-40: http://onlinelibrary.wiley.com/doi/10.1002/uog.12504/abstract;jsessionid=FE45B3F49F6158C129431928AA91297A.d04t03 [accessed 10 February 2015].